News search
 Research 3 Feb 2023 The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease |
 Research 16 Jan 2023 Nature Cardiovascular Research: The 'guardian of the genome' protects against cardiovascular disease A CNIC study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor |
 Research 12 Dec 2022 The results of the SPHERE-HF study are published in the European Journal of Heart Failure. SPHERE-HF is a multicenter academic clinical trial led by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital Clínic de Barcelona |
 Research 3 Nov 2022 CNIC scientists have identified a molecular mechanism that accounts for the arrhythmias, skeletal muscle weakness, and periodic paralysis in patients with this rare disease |
 About the CNIC 2 Nov 2022 A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor |
 |
 About the CNIC 19 Sep 2022 CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference |
 Research 12 Sep 2022 The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease |
 Research 29 Aug 2022 Excess weight and metabolic syndrome are associated with cardiovascular disease, suggesting that health promotion programs in schools should teach good sleep habits |
 Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
- ‹ previous
- 8 of 30
- next ›
